| Affiliation: | 1.Pediatric and Adolescent Drug Development, Children and Young People’s Unit,The Royal Marsden NHS Foundation Trust – Paediatric Offices,Sutton,UK;2.Division of Clinical Studies and Cancer Therapeutics,The Institute of Cancer Research,Sutton,UK;3.Department of Pediatric and Adolescent Oncology, Gustave Roussy, UMR 8203, CNRS,Univ. Paris-Sud,Villejuif,France;4.Clinical Trials Unit, Pediatric Oncology Department,Hospital Infantil Universitario Ni?o Jesús,Madrid,Spain;5.Department of Pediatric, Adolescents and Young Adults Oncology,Institut Curie,Paris,France;6.Department of Pediatric Oncology,Vall d’Hebron Hospital,Barcelona,Spain;7.Department of Pediatric Clinical Trials and Department of Pediatric Neuro-Oncology,Institut Hématologique et d’Oncologie Pédiatrique,Lyon,France;8.Pediatric Oncology Unit,Fondazione IRCCS Istituto Nazionale dei Tumori,Milan,Italy;9.Department of Pediatric Oncology,Birmingham Children’s Hospital,Birmingham,UK;10.Department of Pediatric Oncology,Notthingham Children’s Hospital,Nottingham,UK;11.Université Paris Descartes,Paris,France;12.Pediatric Oncology Unit,Great Ormond Street Hospital for Children NHS Foundation Trust,London,UK;13.Department of Clinical Research, Gustave Roussy,Université Paris-Sud,Villejuif,France |
